EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

CStone’s PD-1 inhibitor CS1003 gets clinical trial approval in China

CStone will initiate a multi-center Phase I clinical trial to assess the safety, tolerability and preliminary anti-tumor activity of CS1003 in Chinese patients with a...
18 July 2018 Asia Pacific | Europe approval | china
Continue Reading →
Asia Pacific

First Hospital, Tbilisi, expands Clinerion’s global network of hospitals into Georgia.

First Hospital, Tbilisi, becomes the first hospital in Georgia to join Clinerion’s global network of hospitals. First Hospital, Tbilisi, is considered one of the best...
3 July 2018 Asia Pacific clinerions | expands
Continue Reading →
Asia Pacific

India’s drug regulator expects to finalize new clinical trial rules in two months

India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the review time, a senior official said on Wednesday, ...
31 May 2018 Asia Pacific | Europe clinical | drug
Continue Reading →
Asia Pacific

Jeil Pharma unveils new research centre

The new research centre is part of the company’s plans to strengthen investment in the R&D sector. Jeil Pharmaceutical has recently opened a new technology rese...
23 May 2018 Asia Pacific | Europe centre | jeil
Continue Reading →
Asia Pacific

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)

Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients Receiving Conventional Therapy at 40 Weeks Ultragenyx Phar...
23 May 2018 Asia Pacific | Europe | North America Kirin | Kyowa
Continue Reading →
Asia Pacific

DCGI seeks response from Glenmark on clinical trial deficiencies by May 12

Indian drug regulator found deficiencies in clinical trial protocols including an alleged falsification of patient enrollment data at Malpani Multispecialty Hospital...
9 May 2018 Asia Pacific | Europe clinical | deficiencies
Continue Reading →
Asia Pacific

Singapore, with strict drug laws, to develop synthetic marijuana compounds

Singapore is funding research on medical treatments containing synthetically-derived compounds of the marijuana plant Singapore, known for some of the world's most ...
2 May 2018 Asia Pacific | Europe drug | Epidiolex
Continue Reading →
Asia Pacific

Who is Responsible for This Jaipur ‘Clinical Trial’ Controversy’?

21 people from Churu district say they came to Jaipur to work for a “medical camp," which may have been a clinical trial, and given drugs of unknown identity. [captio...
25 April 2018 Asia Pacific | Europe clinical | controversy
Continue Reading →
Asia Pacific

9th Annual Clinical Trials Summit 2018

22nd May 2018, Kohinoor Continental Hotel, Mumbai, India “A critical guide for successfully conducting clinical trials” CONFERENCE INTRODUCTION:- With four-out-of-f...
18 April 2018 Asia Pacific | Europe annual | clinical
Continue Reading →
Asia Pacific

Ultragenyx and Kyowa Kirin Announce FDA Approval of Crysvita® (burosumab-twza) for the Treatment of Children and Adults with X–Linked Hypophosphatemia (XLH)

First Approved Therapy for XLH in the U.S.; Only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease Ultragenyx to Host Conference ...
18 April 2018 Asia Pacific | Europe | North America approval | Crysvita
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte